Visudrisone en es it fr

Visudrisone Brand names, Visudrisone Analogs

Visudrisone Brand Names Mixture

  • No information avaliable

Visudrisone Chemical_Formula


Visudrisone RX_link

Visudrisone fda sheet

Visudrisone FDA

Visudrisone msds (material safety sheet)

Visudrisone Synthesis Reference

No information avaliable

Visudrisone Molecular Weight

383.464 g/mol

Visudrisone Melting Point

No information avaliable

Visudrisone H2O Solubility


Visudrisone State


Visudrisone LogP


Visudrisone Dosage Forms

Powder for solution (for injection)

Visudrisone Indication

For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.

Visudrisone Pharmacology

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

Visudrisone Absorption

No information avaliable

Visudrisone side effects and Toxicity

In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, convulsions, and mortalities.

Visudrisone Patient Information

Visudrisone Organisms Affected

Enteric bacteria and other eubacteria